Lymphatic filariasis in six rural villages of yauri local government area, Kebbi state, Nigeria
Keywords:
lymphatic filariasis, ICT, W. bancrofti, yauri, kebbi stateAbstract
The elimination target deadline of 2020 set by the global program for the elimination of lymphatic filariasis (GPELF) is at hand. Mass Drug Administration (MDA) with Albendazole and ivermectin has been going on in yauri LGA for over five years. Apart from the baseline mapping conducted by the state ministry of health in 2010 to identify communities eligible for MDA, no comprehensive research has been carried out on the disease in the area. This study conducted between June and December 2016 was aimed at determining if transmission been halted so that MDA can be stopped. A total of 432 volunteers were tested using onsite filariasis IgG/IgM Combo Rapid test kit and Night blood samples. Clinical manifestations and entomological studies were also conducted. Thirty one participants, 31 (7.18%) tested positive for ICT and 11 (2.55%) for microfilaria of W. bancrofti. Infection rate was slightly higher in zamare village for ICT (P=0.053) and significantly Higher for mf in the same village (P<0.05). Infection rates were higher in males than females, age group 0-9, married than singles and famers than other occupations. However the differences were not statistically significant. No case of chronic physical manifestation was observed. Out of 181 mosquitoes dissected, 1(0.55%) Culex quinquifasciatus was found with microfilaria of W. bancrofti. It was concluded that active transmission of the disease is still going on in Yauri LGA and those who live in Zamare village are at greatest risk of infection. Aggressive sensitization to increase MDA compliance and vector control are recommended.
References
Anosike JC, Nwoke BEB, Ajayi EG, Onwuliri CO, Okoro OU, Asor JE, et al. Lymphatic filariasis among the Ezza people of Ebonyi state, Eastern Nigeria. Annals of Agricultural and Environmental Medicine. 2005;12:181-186.
Eigege A, Richard Jr FO, Blaney DB, Miri ES, Gontor I, Ogar CR, et al. Rapid assessment for lymphatic filariasis in Central Nigeria: A comparism of immunochromatographic card test and hydrocele rates in an area of high endemicity. American Journal of Tropical Medicine and Hygiene. 2002;68(6):643-646.
CDC. Parasites: Lymphatic filariasis, 2010. Accessed on 05/03/11 from http://www.cdc.gov/parasites/lymphaticfilariasis/geninfo/vector/html
World Health Assembly (WHA). A future free of lymphatic filariasis, 2005. Retrieved from http://www.filariasis.org/pdfs/brochures/future-free-of-if English.pdf on 23/01/14
Healthwise. Health Topics A-Z- filariasis: Disease and conditions, 2011. Assessed on 30/12/14 from http://healthmsn.com/health-topics/filariasis.2011
WHO. Lymphatic filariasis Elimination, 2009. Assessed on 21/09/11 from http://www.afro.who.int/lymphaticfilariasiselimin
Better medicine. Lymphatic filariasis, 2011. Accessed on 07/10/11 from www.bettermedicine.com/article/lymphatic filariasis
Badaki JA. Parasitological and social aspect of lymphatic filariasis in Taraba state, Nigeria. Phd. Thesis. University of Jos, Nigeria, 2010.
Wayagankar M. Filariasis, 2011. Assessed on 23/01/14 from http://www.medscape.com/article/
WHO. Forms of lymphatic filariasis and diagnosis, 2011. Assessed on 30/8/15 from http://www.who.int/lymphatic filariasis/epidemiology.forms/en/index.html
WHO. Lymphatic filariasis, 2018. Accessed on 13/5/18 from http://www.who.int/en/news-room/factsheets/detail/ lymphatic-filariasis
Carter. Lymphatic filariasis elimination programme, 2011. Accessed on 03/08/15 from http://www.cartercentre.org.health.index.html
Carter. Two states in Nigeria eliminates disfiguring parasitic disease lymphatic filariasis as a public health problem. Report from carter centre, 2017. Retrieved from https://reliefweb.int
Enenya OA, Cano J Dorigelti I, Anagbogu I, Okoronkwo C, Garske T, Donnelly CA. Environmental suitability for lymphatic filariasis. Parasites and vectors. 2018;11:513.
Gyapong JO, Owusu IO, Da–Costa Vrom FB, Mensah EO, Gyapong M. Elimination of lymphatic filariasis: Current perspective on mass drug administration. Research and reports in Tropical medicine. 2018;9:25-33.
Kanya DY, Usman A, Manga SS, Isyaku NT. An Epidemiological survey of enteric protozoan parasites in school children. Equity Journal of Science and Technology. 2013;1(1):30-32.
Shehu A. Kebbi state: yesterday and today multinational concept, Lagos (Unpublished), 2014, 433p.
Cheesbrough M. District laboratory practice on Tropical countries part 1 (2nd ed). Cambridge University Press, 2005, p454.
Braide EI, Ikpeme B, Edet E Atting I, Ekpo UF, ESU B, Kale OO. Priliminary observations on the occurrence of Lyphatic filariasis in Cross River state, Nigeria. Nigeria Journal of Parasitology. 2003;24:9-16.
Nwoke BEB, Dozie INS, Jiya J, Sake Y, Ogidi JA, et al. The prevalence of hydrocele in Nigeria and its implication on mapping of Lyphatic filariasis. Nigeria Journal of parasitology. 2006;27:29-35.
Dogara MM, Nock H, Agbede R, Ndams S, Kumbur J. Entomological survey ofmosquitoes responsible for the transmission of Lyphatic filariasis in three endemic villages of kano state, Nigeria. Internet Journal of World Health and Societal Politics, 2014, 7(2). Doi: 10.5580/2644
Attah OA, Adamu T, Yahaya MM, Farouq AA, Bala AY, Kanya DY, Ukatu VE. Lyphatic filariasis in some words in Bodinga Local Government Area of Sokoto state, Nigeria. Continental Journal of Biological Sciences. 2017;10(1):12-21.
Singh AK, Agurwal L, Lakhmani K, Sengupta C, Singh RP. Detection of antifilarial antibody among hydrocele patients living in an endemic area for filariasis. Journal of Family Medicine and Primary Care. 2016;5(3):553-557.
Ladan U, Tukur M, Sirajo IM. Seroprevalence of Lyphatic filariasis in six communities of Bungudu LGA, Zamfara State, Nigeria. International Journal of Pure and Applied Bioscience. 2018;6(3):11-18.
Ruberanziza E, Mufasoni D, Kanbushi F, Rujeni N, Kabanda G, Kabera M, et al. Mapping of Lymphatic filariasis in Rwanda. Journal of Lymphoedema. 2009;4(1):20-23.
WHO. Lymphatic filariasis fact sheet No. 190, 1998. Accessed on 03/03/12 from http://apps.who.int/int.fs/en/fact190.html1998
Dogara MM, Nock H, Agbede R, Ndams S, Kumbur J. Prevalence of Lymphatic filriasis in three villages in three villages in kano state, Nigeria. The Internet Journal of Tropical Medicine. 2012;8(1):P10.
Ojukwu I, Njom V. Prevalence of Lymphatic filariasis in Amichi, Nnewi south LGA Anambra state, Nigeria. Journal of Health and Visual Sciences, 2012, 14(I).
Ichimori K, King JD, Ottesen EA. Global programme to Eliminate Lymphatic filariasis: The process underlying success. PLoS Negleted Tropical Disease. 2014;8(12):e3328.
Ezeabikwa IN, Ivoke BO, Ekeh FN, Ezenwaji NE, Odo GE, Ongu US, Eyo JE. Wuchereria bancrofti infection in rural tropical guinea savannah communities: Rapid epidemiological assessment using ICT card test and prevalence of hydrocele. Tropical Biomedicine. 2015;32(2):365-375.
Adekunle NO, Sam-Wobo SO, Adeleke MA, Ekpo UF, Davis E, Ladokun AO, et al. Prevalence and distribution of W. bancrofti is Ose LGA, Ondo state Nigeria. Nigerian Journal of Parasitology. 2016;37(1):96-100.
Mba M, Okafor L, Useh MF, Ejezie GC, Alaribe AAA. Studies on the diagnosis and transmission dynamics of Lyphatic filariasis in Biase LGA, Cross River state, Nigeria 4th international conference on medical Biological and Pharmaceutical sciences, Dubai, 2013. http://psrcentre.org/extraimages/18%201013:019.pdf
Hayatudden S, Abdullahi UY, Dauda MM. Epidemiology of Lyphatic filariasis in Danbata and Kumyotso LGAs of Kano state, Nigeria. International Journal of sciences, Basic and applied Research (IJSBAR), 2016. Retrieved from http://gssrr.org/wider.php on 9/10/17
Okorie PN, Davies E, Ogunmola OO, Ojurongbe O, Saka Y, Okoeguale B, et al. Lyphatic filariasis baseline survey in two sentinel sites of Ogun state. Nigerian Pan Africa Medical Journal. 2015;20:397.
